Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Vijayabhanu Mahadevan (NPI 1083727333)

Field	Value
Entity Type	Individual
Organization	Vijayabhanu Mahadevan
Address	12665 W Smokey Dr # 140
City	Surprise
State	AZ
ZIP	85378
Taxonomy	Rheumatology Physician
NPI Enumerated	August 17, 2006

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider’s commercial footprint is effectively single-payer: lifetime Medicare revenue is $2.6M and there is no Medicaid billing on file, indicating the practice’s Medicare business drives its public-payer volume and cash flow. Analysts should treat this profile as Medicare-centric when assessing network value or contract negotiations.

Revenue concentration is high within a small set of drug-administration codes: the precomputed top 3 Medicare codes by revenue account for 57.8% of this provider's total Medicare revenue, led by J0129 ($677.5K, 25.9%), J0897 ($462.2K, 17.7%), and J0717 ($374.4K, 14.3%). This indicates most Medicare dollars are tied to a few injectable biologics rather than routine office E&M.

The code mix strongly signals a physician-administered biologics and infusion service model: high-revenue codes include J0129 (abatacept), J0897 (denosumab), J0717 (certolizumab), J3262 (tocilizumab), J9312 (rituximab), and J1745 (infliximab), and multiple chemotherapy/infusion administration codes appear on the top list (96401, 96413, 96415). Taken together, these entries point to on-site drug administration and infusion capacity consistent with a rheumatology practice that bills for complex biologics.

Several Medicare codes show statistically exceptional volume relative to national peers: J0897 ranks #145 of 10057 providers (99th percentile; extreme outlier), 99214 ranks #6295 of 479517 providers (99th percentile; extreme outlier), and 96401 ranks #56 of 3868 providers (99th percentile; extreme outlier). These designations suggest this provider administers denosumab, delivers E&M visits, and performs infusion/chemo administrations at volumes that are far above typical national peers for those services.

Other high-revenue biologic codes sit at or near typical peer levels rather than being outliers: J0129 (rank #140 of 1221, 89th percentile; typical, unremarkable volume), J0717 (rank #166 of 848, 81th percentile; typical, unremarkable volume), and J3262 (rank #136 of 618, 78th percentile; typical, unremarkable volume). This pattern—one extreme outlier alongside several typical-volume biologics—suggests concentration in particular drug lines rather than uniformly elevated dispensing across all biologic agents.

Office evaluation-and-management codes generate measurable but modest Medicare revenue relative to biologics: 99214 produced $111.6K (4.3% of Medicare revenue) and 99213 produced $51.3K (2.0% of Medicare revenue). Although 99214 is flagged as an extreme outlier in ranking, total E&M dollars remain small compared with top drug codes, reinforcing an operational focus on drug delivery rather than E&M-driven revenue.

The provider has long tenure in the Medicare program, with an NPI enumeration date of 2006-08-17 (~20 years ago), which supports the likelihood of an established referral base and experience managing longitudinal biologic and infusion therapies. For competitive analysis, tenure combined with concentrated biologic volumes suggests durable capability to sustain a specialty infusion service within the local SURPRISE, AZ market.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

29 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	19,930	$30	$677.5K
J0897	Injection, denosumab, 1 mg	25,680	$20	$462.2K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	93,600	$1	$374.4K
J3262	Injection, tocilizumab, 1 mg	68,560	$10	$342.8K
J9312	Injection, rituximab, 10 mg	3,250	$60	$208K
J3111	Injection, romosozumab-aqqg, 1 mg	18,060	$10	$144.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,250	$90	$111.6K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	3,050	$30	$79.3K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	1,070	$50	$55.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	550	$100	$52.9K

Showing 1–10 of 29

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 29 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Vijayabhanu Mahadevan — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

29 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	6	30	14,700	$30	$494.5K
J3262	12	20	74,500	$1	$367.2K
J0717	4	20	36,100	$1	$246.6K
J9312	8	20	3,250	$60	$212.6K
J3111	23	40	19,530	$10	$178.8K
J0897	12	260	2,940	$20	$115.6K
J1745	17	40	2,980	$30	$103.9K
96413	25	230	190	$100	$24.8K
99214	276	10,410	120	$80	$20.6K
99215	969	3,270	50	$120	$11.9K

Showing 1–10 of 29

Related Providers

Other providers that share a Tax Identification Number (TIN) with Vijayabhanu Mahadevan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rajbir Gulati	AZ	Rheumatology Physician	$1.3M	$0

Nearby Providers

Other providers in the same ZIP code as Vijayabhanu Mahadevan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Halo Community Services	AZ	Case Management Agency	$0	$21.1M
Becky Home Health Care, LLC	AZ	Home Health Agency	$0	$15.2M
Andy Tran	AZ	Clinical Cardiac Electrophysiology Physician	$683.1K	$0
Jay Mehta	AZ	Dermatology Physician	$603K	$0
Vascular Imaging Solutions LLC	AZ	Diagnostic Ultrasound Physician	$96K	$308.8K
Adam Calarese	AZ	Vascular Surgery Physician	$386.8K	$0
Nirav Mehta	AZ	Interventional Cardiology Physician	$290.7K	$0
Stephen Smith	AZ	Vascular Surgery Physician	$236.4K	$0
Lawrence Kelly	AZ	Orthopaedic Surgery Physician	$184.3K	$0
Rohit Dwivedi	AZ	Specialist	$150.2K	$0

Vijayabhanu Mahadevan — Billing Profile & Reimbursement Data

Sign up for Vijayabhanu Mahadevan — Billing Profile & Reimbursement Data policy alerts

Vijayabhanu Mahadevan — Billing Profile & Reimbursement Data

Sign up for Vijayabhanu Mahadevan — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References